Cargando…

Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation

The human hCLCA1 gene is a member of the CLCA gene family that has a well-documented role in inflammatory airway diseases. Previously, we demonstrated that secreted hCLCA1 plays a role in regulating the innate immune response by activating airway macrophages. However, the mechanism of this regulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Keith, Brandon A., Ching, John C.H., Loewen, Matthew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444176/
https://www.ncbi.nlm.nih.gov/pubmed/30984882
http://dx.doi.org/10.1016/j.bbrep.2019.100630
_version_ 1783407979578523648
author Keith, Brandon A.
Ching, John C.H.
Loewen, Matthew E.
author_facet Keith, Brandon A.
Ching, John C.H.
Loewen, Matthew E.
author_sort Keith, Brandon A.
collection PubMed
description The human hCLCA1 gene is a member of the CLCA gene family that has a well-documented role in inflammatory airway diseases. Previously, we demonstrated that secreted hCLCA1 plays a role in regulating the innate immune response by activating airway macrophages. However, the mechanism of this regulation remains unclear. In this present study, recombinant proteins containing different hCLCA1 domains are expressed to determine the specific hCLCA1 domain(s) responsible for macrophage activation. Specifically, hCLCA1 constructs containing the hydrolase domain (HYD), the von Willebrand Factor Type A (VWA) domain, and the fibronectin type III (FN3) domain were heterologously expressed and affinity purified through fast protein liquid chromatography. Circular dichroism spectroscopy revealed that the purified hCLCA1 constructs exhibited secondary structure consistent with folded proteins. The VWA domain clearly demonstrated an ability to activate macrophages, inducing an increase in both IL-1β mRNA and protein expression. This activation was associated with the activation of MAPKs and NF-κB pathways, identifying potential mechanistic pathways by which hCLCA1's VWA domain exerts its signaling effect. Altogether, this work identifies a domain with signaling function within hCLCA1, providing a specific target to one of the most highly induced gene products of airway inflammatory disease.
format Online
Article
Text
id pubmed-6444176
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64441762019-04-12 Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation Keith, Brandon A. Ching, John C.H. Loewen, Matthew E. Biochem Biophys Rep Research Article The human hCLCA1 gene is a member of the CLCA gene family that has a well-documented role in inflammatory airway diseases. Previously, we demonstrated that secreted hCLCA1 plays a role in regulating the innate immune response by activating airway macrophages. However, the mechanism of this regulation remains unclear. In this present study, recombinant proteins containing different hCLCA1 domains are expressed to determine the specific hCLCA1 domain(s) responsible for macrophage activation. Specifically, hCLCA1 constructs containing the hydrolase domain (HYD), the von Willebrand Factor Type A (VWA) domain, and the fibronectin type III (FN3) domain were heterologously expressed and affinity purified through fast protein liquid chromatography. Circular dichroism spectroscopy revealed that the purified hCLCA1 constructs exhibited secondary structure consistent with folded proteins. The VWA domain clearly demonstrated an ability to activate macrophages, inducing an increase in both IL-1β mRNA and protein expression. This activation was associated with the activation of MAPKs and NF-κB pathways, identifying potential mechanistic pathways by which hCLCA1's VWA domain exerts its signaling effect. Altogether, this work identifies a domain with signaling function within hCLCA1, providing a specific target to one of the most highly induced gene products of airway inflammatory disease. Elsevier 2019-03-28 /pmc/articles/PMC6444176/ /pubmed/30984882 http://dx.doi.org/10.1016/j.bbrep.2019.100630 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Keith, Brandon A.
Ching, John C.H.
Loewen, Matthew E.
Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation
title Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation
title_full Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation
title_fullStr Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation
title_full_unstemmed Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation
title_short Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation
title_sort von willebrand factor type a domain of hclca1 is sufficient for u-937 macrophage activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444176/
https://www.ncbi.nlm.nih.gov/pubmed/30984882
http://dx.doi.org/10.1016/j.bbrep.2019.100630
work_keys_str_mv AT keithbrandona vonwillebrandfactortypeadomainofhclca1issufficientforu937macrophageactivation
AT chingjohnch vonwillebrandfactortypeadomainofhclca1issufficientforu937macrophageactivation
AT loewenmatthewe vonwillebrandfactortypeadomainofhclca1issufficientforu937macrophageactivation